The story of the erectile dysfunction drug presents a complex picture for shareholders. While the initial release generated massive profits, the end of its intellectual property protection opened the avenue to cheaper https://bookmarkingfeed.com/story21533629/viagra-and-big-pharma-a-precarious-opportunity